Fate Therapeutics Inc (FATE) stock is down -90.00% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives FATE stock a score of 35 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 1. FATE's rank also includes a long-term technical score of 7.
FATE has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on FATE!
Fate Therapeutics Inc (FATE) stock has fallen -0.78% while the S&P 500 is down -0.19% as of 9:39 AM on Tuesday, Sep 19. FATE is down -$0.02 from the previous closing price of $2.55 on volume of 1,427 shares. Over the past year the S&P 500 has risen 13.99% while FATE is down -90.00%. FATE lost -$2.17 per share in the over the last 12 months.
Click Here to get the full Stock Report for Fate Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
